Nventric, a Arcadia-based medical device developer specializing in neurovascular, coronary, and peripheral vascular applications, is relocating and expanding its Southern California footprint along...
ByThe RegistryJune 16, 2026Reotemp Instrument signs a 12-year, 75,000-square-foot full-building lease at Luminous Capital's repositioned Scripps Ranch asset.
ByThe RegistryJune 15, 2026San Diego has landed among the four markets leading the U.S. life sciences real estate recovery, buoyed by the region’s largest lab lease...
ByThe RegistryJune 12, 2026Peregren Capital Group’s loan, with $162.5 million in future funding, gives the vacant Pacific Center runway to lease up in a market where...
ByThe RegistryJune 5, 2026Peregren Capital Group provided the loan, which includes $162.5 million of future funding, as the joint venture pushes leasing at its newly delivered...
ByThe RegistryMay 28, 2026LBA Realty and CBRE leaders point to eight straight quarters of office absorption, a thawing industrial capital market and a diversified Southern California...
ByThe RegistryMay 15, 2026The university’s adaptive reuse play to convert a dead mall into a multidisciplinary science campus moves into formal CEQA review, with a public...
ByThe RegistryMay 14, 2026REIT’s University Town Center anchor leases offset Sorrento Mesa weakness as countywide vacancy hits historic highs. San Diego’s life science real estate market...
ByThe RegistryApril 28, 2026The world’s largest alternative asset manager is betting its real estate franchise on AI infrastructure while waiting for logistics and multifamily to rebound...
ByThe RegistryApril 24, 2026Savills says supply surge from pandemic-era development boom is outpacing demand, leaving major lab projects unleased across key hubs A development cycle that...
ByThe RegistryApril 16, 2026A pandemic-era construction wave has collided with cooling demand, leaving nearly 60 million square feet of new lab space struggling to find tenants...
ByThe RegistryApril 9, 2026Biopharmaceutical firm leases space as it advances sustained drug delivery technology toward commercialization. SpyGlass Pharma Inc, a late-stage biopharmaceutical company focused on transforming...
ByThe RegistryMarch 27, 2026Error: Contact form not found.